Evidence map›Paper›PMID 40721525›Full record

ArticleEuropean journal of human genetics : EJHG2025

Mechanistic insights into 16p13.3 microdeletions encompassing TBC1D24 and ATP6V0C through advanced sequencing approaches.

Benoit Mazel, Emilia Aisha Coleman, Justine Rousseau, Senthilkumar Kailasam, Norbert Fonya Ajeawung, Daniel Alexander Jimenez Cruz, Sophie Ehresmann, Gang Chen, Carl Ernst, Philippe M Campeau

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. What's new in EJHG this autumn.European journal of human genetics : EJHG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Benoit Mazel *Centre de Recherche Azrieli du CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.ORCID 0000-0002-1788-1495
Emilia Aisha Coleman *Centre de Recherche Azrieli du CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
Justine RousseauCentre de Recherche Azrieli du CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
Senthilkumar KailasamCanadian Center for Computational Genomics, Montréal, QC, Canada.
Norbert Fonya AjeawungCentre de Recherche Azrieli du CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada.
Daniel Alexander Jimenez CruzBioinformatics Platform, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
Sophie EhresmannMolecular Biology Program, Université de Montréal, Montréal, QC, Canada.ORCID 0000-0002-4171-7222
Gang ChenPsychiatric Genetics Group, Douglas Hospital Research Institute, McGill University, Montreal, QC, Canada.
Carl ErnstDepartment of Human Genetics, McGill University, Montréal, QC, Canada.ORCID 0000-0002-2959-221X
Philippe M CampeauCentre de Recherche Azrieli du CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada. p.campeau@umontreal.ca.ORCID 0000-0001-9713-7107

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 137093
6 · The paper itself

Abstract

Chromosomal microdeletions represent a complex class of genetic disorders. Recently, 16p13.3 microdeletions encompassing TBC1D24 and ATP6V0C have gained prominence as structural variants associated with neurodevelopmental disorders, but their occurrence mechanisms remain unexplored. We used a comprehensive range of sequencing technologies (mate pair genome sequencing, linked-pair genome sequencing, nanopore sequencing, targeted locus amplification (TLA), long range and nested PCR followed by Sanger sequencing), to map the exact 16p13.3 microdeletion breakpoints in eight previously reported individuals. Microdeletion breakpoints were successfully mapped in all patients using TLA, split read analysis, PCR/Sanger sequencing, or nanopore sequencing. Alu sequences and/or non-B DNA motifs were detected in all patients. Mechanistic analysis identified distinct pathways underlying these rearrangements. Noteworthy, two unrelated individuals carried identical microdeletions that might have been mediated by an atypical form of non-allelic homologous recombination, given the presence of a 639 bp sequence with 96.2% homology. Microhomology-mediated end-joining and non-homologous end-joining emerged as other mechanisms driving these 16p13.3 microdeletions, which differs from other studied contiguous gene deletion syndromes. This research contributes to a deeper understanding of microdeletion-associated disorder pathophysiology in medical genetics.

Indexed as

Carrier ProteinsChromosome DeletionChromosomes, Human, Pair 16GTPase-Activating ProteinsChildChild, PreschoolChromosome BreakpointsFemaleHumansMaleCarrier ProteinsGTPase-Activating ProteinsTBC1D24 protein, human

Identifiers

PMID40721525
PMCPMC12402159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.